{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:05:45Z","timestamp":1791050745652,"version":"4.1.0"},"reference-count":24,"publisher":"Japan Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1507\/endocrj.ej12-0332","type":"journal-article","created":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T10:15:12Z","timestamp":1351505712000},"page":"185-189","source":"Crossref","is-referenced-by-count":22,"title":["The relationship between bone marrow characteristics and the clinical prognosis of antithyroid drug-induced agranulocytosis"],"prefix":"10.1507","volume":"60","author":[{"given":"Jing","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Metabolism & Endocrinology of the first affiliated hospital, University of South China, Hengyang 421001, China"},{"name":"Department of Pathophysiology, University of South China, Changsheng Road, Hengyang 421001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhong","sequence":"additional","affiliation":[{"name":"Clinical Medical Research Institute of the First Affiliated Hospital, University of South China, Hengyang 421001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Hua","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Metabolism & Endocrinology of the first affiliated hospital, University of South China, Hengyang 421001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Zhi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Clinical Medical Research Institute of the First Affiliated Hospital, University of South China, Hengyang 421001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Jun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, University of South China, Changsheng Road, Hengyang 421001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Hua","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Metabolism & Endocrinology of the first affiliated hospital, University of South China, Hengyang 421001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-Xian","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Metabolism & Endocrinology of the first affiliated hospital, University of South China, Hengyang 421001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge-Bo","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Metabolism & Endocrinology of the first affiliated hospital, University of South China, Hengyang 421001, China"},{"name":"Clinical Medical Research Institute of the First Affiliated Hospital, University of South China, Hengyang 421001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra042972"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Thomas D, Moisidis A, Tsiakalos A, Alexandraki K, Syriou V, <i>et al.<\/i> (2008) Antithyroid drug-induced aplastic anemia. <i>Thyroid<\/i> 18:1043-1048.","DOI":"10.1089\/thy.2008.0097"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1089\/105072504323150787"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Sheng WH, Hung CC, Chen YC, Fang CT, Hsieh SM, <i>et al.<\/i> (1999) Antithyroid-drug-induced agranulocytosis complicated by life-threatening infections. <i>QJM<\/i> 92:455-461.","DOI":"10.1093\/qjmed\/92.8.455"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Andres E, Zimmer J, Mecili M, Weitten T, Alt M, <i>et al.<\/i> (2011) Clinical presentation and management of drug-induced agranulocytosis. <i>Expert Rev Hematol<\/i> 4:143-151.","DOI":"10.1586\/ehm.11.12"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Douer D, Eisenstein Z (1988) Methimazole-induced agranulocytosis: growth inhibition of myeloid progenitor cells by the patient&rsquo;s serum. <i>Eur J Haematol<\/i> 40:91-94.","DOI":"10.1111\/j.1600-0609.1988.tb00803.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sun MT, Tsai CH, Shih KC (2009) Antithyroid drug-induced agranulocytosis. <i>J Chin Med Assoc<\/i> 72:438-441.","DOI":"10.1016\/S1726-4901(09)70402-2"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Tajiri J, Noguchi S, Okamura S, Morita M, Tamaru M, <i>et al.<\/i> (1993) Granulocyte colony-stimulating factor treatment of antithyroid drug-induced granulocytopenia. <i>Arch Intern Med<\/i> 153:509-514.","DOI":"10.1001\/archinte.1993.00410040073011"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.77.5.1356"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb08042.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Waldhauser L, Uetrecht J (1991) Oxidation of propylthiouracil to reactive metabolites by activated neutrophils. Implications for agranulocytosis. <i>Drug Metab Dispos<\/i> 19:354-359.","DOI":"10.1016\/S0090-9556(25)07126-0"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01720.x"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02029.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tajiri J, Noguchi S, Murakami T, Murakami N (1990) Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring. <i>Arch Intern Med<\/i> 150:621-624.","DOI":"10.1001\/archinte.1990.00390150107020"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Watanabe N, Narimatsu H, Noh JY, Yamaguchi T, Kobayashi K, <i>et al.<\/i> (2012) Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves&rsquo; disease. <i>J Clin Endocrinol Metab<\/i> 97:E49-53.","DOI":"10.1210\/jc.2011-2221"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Biswas N, Ahn YH, Goldman JM, Schwartz JM (1991) Aplastic anemia associated with antithyroid drugs. <i>Am J Med Sci<\/i> 301:190-194.","DOI":"10.1097\/00000441-199103000-00008"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Moreb J, Shemesh O, Shilo S, Manor C, Hershko C (1983) Transient methimazole-induced bone marrow aplasia: in vitro evidence for a humoral mechanism of bone marrow suppression. <i>Acta Haematol<\/i> 69:127-131.","DOI":"10.1159\/000206873"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yamamoto A, Katayama Y, Tomiyama K, Hosoai H, Hirata F, <i>et al.<\/i> (2004) Methimazole-induced aplastic anemia caused by hypocellular bone marrow with plasmacytosis. <i>Thyroid<\/i> 14:231-235.","DOI":"10.1089\/105072504773297911"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Cooper DS, Goldminz D, Levin AA, Ladenson PW, Daniels GH, <i>et al.<\/i> (1983) Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. <i>Ann Intern Med<\/i> 98:26-29.","DOI":"10.7326\/0003-4819-98-1-26"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.51.7845"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Andres E, Kurtz JE, Perrin AE, Dufour P, Schlienger JL, <i>et al<\/i>. (2001) Haematopoietic growth factor in antithyroid-drug-induced agranulocytosis. <i>QJM<\/i> 94:423-428.","DOI":"10.1093\/qjmed\/94.8.423"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Fukata S, Kuma K, Sugawara M (1999) Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study. <i>Thyroid<\/i> 9:29-31.","DOI":"10.1089\/thy.1999.9.29"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2005.15.292"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Lieschke GJ, Burgess AW (1992) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (first of two parts). <i>N Engl J Med<\/i> 327:28-35.","DOI":"10.1056\/NEJM199207023270106"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/60\/2\/60_EJ12-0332\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T17:01:35Z","timestamp":1745082095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/60\/2\/60_EJ12-0332\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej12-0332","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}